|
Phase 3 KEYNOTE-361 trial: Pembrolizumab (pembro) with or without chemotherapy versus chemotherapy alone in advanced urothelial cancer. |
|
|
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Merck; Novartis |
Research Funding - AstraZeneca/MedImmune; Roche/Genentech |
|
|
Honoraria - Bayer Schering Pharma; Janssen-Cilag |
Consulting or Advisory Role - Bayer Schering Pharma; Janssen-Cilag |
|
|
Honoraria - Astellas Medivation; Ipsen; Janssen; Roche |
Consulting or Advisory Role - Astellas Pharma; Janssen; MSD; Roche |
Research Funding - Sanofi (Inst) |
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Merck; Roche |
|
|
Consulting or Advisory Role - Astellas Pharma; Genentech; Merck; Novartis; Pfizer; Pierre Fabre |
Research Funding - Millennium (Inst); Sanofi (Inst) |
Travel, Accommodations, Expenses - MSD Oncology; Pfizer |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - LEO Pharma; Novartis; Roche |
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche |
|
|
Honoraria - Amgen; Merck; Pfizer; Roche |
Consulting or Advisory Role - Amgen; Astellas Oncology; Merck; Pfizer |
Speakers' Bureau - Novartis; Pfizer |
|
Travel, Accommodations, Expenses - Amgen; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Virginia Oncology Associates |
Speakers' Bureau - Genentech; Medivation/Astellas |
Travel, Accommodations, Expenses - Genentech; Medivation/Astellas |
|
|
Consulting or Advisory Role - bioTheranostics |
|
|
No Relationships to Disclose |
|
Christian Heinrich Poehlein |
Employment - Bayer; Merck |
Patents, Royalties, Other Intellectual Property - Earle A. Chiles Research Institute; Providence |
|
|
|
Consulting or Advisory Role - Eisai |
Research Funding - BIND Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Novartis (Inst); Oncogene Science (Inst) |